Tuesday, September 2, 2014
Inquirer Daily News

Breast Cancer

  • More Top Stories
  • Latest News
Women choosing the procedure gained just one to seven extra months of life over 20 years, researchers say
Letrozole improves pregnancy rates in women with polycystic ovary syndrome, researcher says
But little research is done on male treatments, expert says
Physical activity linked to improved survival odds, experts say
A national study of nearly half a million women found that adding three-dimensional breast imaging to standard two-dimensional mammography increased cancer detection while reducing recalls for false alarms.
But many aren't getting treated for the condition, researchers say
The first time she was diagnosed with breast cancer, Caren Kaufman was 37. She had the surgery, the chemo, the radiation.
Breast cancer patients with small-sized tumors have a low risk of cancer recurrence, even without chemotherapy and an especially potent drug called trastuzumab.
Study suggests routine sample might provide information critical to treatment
Breast cancer survivors may benefit from taking the estrogen-blocking drug for up to 10 years, experts say
Most were satisfied with their decision, researchers noted
Screening shouldn't be done when patients have less than a 10-year life expectancy, researchers say
Research confirms findings previously noted for whites
Experts think anti-inflammatory drugs like aspirin might help cancer treatments work better
Instead, low estrogen might be the beneficial factor, researcher suggests
Instead, low estrogen might be the beneficial factor, researcher suggests
But the effect quickly fades once workouts stop, researchers noted
Report details success of CDC program for women with limited health care access
Categorizing tumors by cell type and not the organ they grow in may alter treatment, experts say
One in three women with PALB2 mutation will develop disease by age 70
Study says early-stage cancer detection is key, but another expert says it may lead to 'overtreatment'
High-dose estrogen formulations linked to greater risk in women under 50, experts find
Women choosing the procedure gained just one to seven extra months of life over 20 years, researchers say
It produced lower 5-year recurrence rates compared to tamoxifen, but didn't boost overall survival, study finds